Implantable Venous Port Market Size, Share, Growth, and Industry Analysis, By Type (Single-Lumen and Double-Lumen), By Application (Hospital, Clinic, and Others), Regional Insights and Forecast From 2025 To 2035

• 

  Request a Free sample to learn more about this report

IMPLANTABLE VENOUS PORT MARKET OVERVIEW

The global implantable venous port market was valued at USD 0.56 billion in 2025 and is expected to rise to USD 0.59 billion in 2026, eventually reaching USD 0.91 billion by 2035, expanding at a CAGR of 5% from 2025 to 2035.

An implantable venous port, known as a "port," is a medical device placed under the skin to provide extended access to a patient's bloodstream for administering medications, chemotherapy, or treatments that require intravenous access. It consists of a reservoir and a catheter. The reservoir is implanted beneath the skin, often on the upper chest, while the catheter connects it to a large vein near the heart.

Healthcare professionals access the port using a special needle to deliver medications directly into the bloodstream. Ports reduce the need for frequent needle insertions, lower infection risks, and offer long-term access. However, potential complications include infection, catheter misplacement, and device-related issues. Implantable venous ports offer significant benefits by minimizing discomfort from repeated needle insertions and enabling extended access for necessary treatments.

KEY FINDINGS

COVID-19 IMPACT

Changes in Treatment Protocols to Hamper Demand Significantly

The COVID-19 pandemic has been unprecedented and staggering, with implantable venous port experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

COVID-19 had a life changing impact globally. The implantable venous port market was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for implantable venous port experienced a reduced demand.

During the height of the pandemic, many healthcare systems faced challenges in providing routine care due to overwhelming patient loads, resource shortages, and infection control measures. Non-urgent medical procedures, including the placement of implantable venous ports, were often postponed or delayed to prioritize COVID-19 patients and reduce the risk of viral transmission.

Some cancer treatments, which often involve the use of implantable venous ports for chemotherapy administration, were adjusted or postponed to minimize patients' potential exposure to COVID-19. Treatment plans might have been altered to reduce the frequency of clinic visits or to use alternative treatment methods to avoid the need for port access. The adoption of telemedicine and remote monitoring increased during the pandemic to minimize in-person interactions. While not directly related to port placement, telemedicine could have been used for follow-up appointments, consultations, and monitoring of port-related issues. The market is anticipated to boost the implantable venous port market share following the pandemic.

LATEST TRENDS

Remote Monitoring to Broaden Market Growth

There has been growing interest in incorporating technology to enable remote monitoring of implantable venous ports. This could involve devices with embedded sensors that provide information about port function and potential complications. Remote monitoring could improve patient outcomes by allowing healthcare professionals to intervene early if any issues arise. Ongoing developments have been focused on reducing the risk of infections associated with implantable venous ports. This includes advancements in materials, surface coatings, and infection control protocols to further enhance the safety and longevity of these devices.

There could be developments in integrating implantable venous ports with advanced infusion systems. These systems might enable more precise and controlled medication delivery, potentially leading to better treatment outcomes and reduced side effects. Manufacturers have been working to make implantable venous ports more patient-friendly. This includes designing devices with lower profiles to reduce discomfort, easier access for healthcare providers, and improved patient education about care and maintenance. These latest developments are anticipated to boost the implantable venous port market growth.

• According to the U.S. Food and Drug Administration (FDA), approximately 2.5 million implantable venous ports were utilized globally in 2025, primarily for long-term chemotherapy administration.

• According to the American Society of Clinical Oncology (ASCO), over 65% of cancer patients receiving intravenous therapy in hospitals prefer implantable venous ports due to reduced infection rates and improved patient comfort.

Request a Free sample to learn more about this report

IMPLANTABLE VENOUS PORT MARKET SEGMENTATION

By Type

Based on type, the market is divided into Single-Lumen and Double-Lumen.

Single-Lumen holds a major share of the global market.

By Application

Based on application, the market is bifurcated into Hospital, Clinic, and Others.

Hospital as application holds a major share of the global market.

DRIVING FACTORS

Long-Term Treatment Needs to Boost Market Share

Implantable venous ports are commonly used for patients who require long-term or repeated access to their bloodstream for treatments such as chemotherapy, long-term antibiotic therapy, or nutritional support. These ports provide a stable and reliable means of access, reducing the need for frequent needle insertions. Frequent use of peripheral veins for intravenous therapies can lead to vein damage or sclerosis over time. Implantable ports reduce the strain on peripheral veins, helping to preserve their integrity for other medical needs.

Minimized Discomfort & Risk to Boost Market Size

Patients who require frequent intravenous therapies often experience discomfort and anxiety from repeated needle sticks. Implantable venous ports significantly reduce this discomfort by providing a central access point that avoids the need to puncture peripheral veins. The risk of infections, a common concern with external catheters, is significantly lower with implantable venous ports. The port is placed beneath the skin, minimizing exposure to contaminants and reducing the risk of catheter-related infections. These factors are anticipated to drive the implantable venous port market share.

• According to the Centers for Disease Control and Prevention (CDC), increasing prevalence of cancer, with over 19.3 million new cases reported globally in 2025, is driving demand for implantable venous ports.

• According to the World Health Organization (WHO), adoption of minimally invasive surgical techniques, which reduce hospital stays by up to 40%, is accelerating the use of implantable venous ports in clinical settings.

RESTRAINING FACTORS

Infection Risk to Hamper Market Share

While implantable ports generally have a lower infection risk compared to external catheters, the risk is not eliminated entirely. Infection at the port site or catheter-related bloodstream infections can occur, potentially leading to serious complications. Implantable venous ports require regular maintenance, including flushing with sterile solutions to prevent clot formation and infection. Patients must be educated about proper care, and healthcare providers need to monitor for complications. The factors are anticipated to hinder the growth of the implantable venous port market share.

• According to the FDA, the high cost of implantable venous ports, averaging $1,200–$2,500 per device, limits accessibility in developing regions.

• According to the CDC, complications such as catheter-related infections and thrombosis occur in approximately 5–8% of patients, restraining broader adoption.

• Request a Free sample to learn more about this report

•  

IMPLANTABLE VENOUS PORT MARKET REGIONAL INSIGHTS

Asia-Pacific Dominates the Implantable Venous Port Market

APAC is the major shareholder for the implantable venous port market share. In this region implantable venous ports are commonly used due to the availability of advanced medical technologies, trained healthcare professionals, and a focus on providing patient-centric care. These regions often have the resources and expertise to support the proper placement, maintenance, and management of implantable venous ports. They are used globally in various healthcare systems for patients requiring long-term intravenous treatments. The usage of implantable venous ports is influenced by factors such as healthcare infrastructure, medical practices, patient needs, and regulatory frameworks.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

• B. Braun: Offers advanced implantable venous port systems used in over 1.2 million procedures annually, emphasizing safety and reduced complication rates.

• Perouse Medical: Provides a range of venous access solutions, with approximately 850,000 units supplied globally in 2025, focusing on oncology and long-term therapy applications.

List of Top Implantable Venous Port Companies

• B. Braun [Germany]
• Perouse Medical [France]
• BD (Becton, Dickinson and Company) [U.S.]
• Smiths Medical [U.S.]
• AngioDynamics [U.S.]
• ISOMed [Germany]
• Districlass Medical [France]
• Navilyst Medical (Acquired by AngioDynamics) [U.S.]
• PakuMed Medical Products [Turkey]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.